Johnson & Johnson (JNJ)
146.82
-1.71
(-1.15%)
USD |
NYSE |
Apr 25, 16:00
146.50
-0.32
(-0.22%)
After-Hours: 20:00
Johnson & Johnson SG&A Expense (Annual): 21.51B for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 21.51B |
December 31, 2022 | 20.25B |
December 31, 2021 | 20.12B |
December 31, 2020 | 22.08B |
December 31, 2019 | 22.18B |
December 31, 2018 | 22.54B |
December 31, 2017 | 21.52B |
December 31, 2016 | 20.07B |
December 31, 2015 | 21.20B |
December 31, 2014 | 21.95B |
December 31, 2013 | 21.83B |
December 31, 2012 | 20.87B |
December 31, 2011 | 20.97B |
December 31, 2010 | 19.42B |
December 31, 2009 | 19.80B |
December 31, 2008 | 21.49B |
December 31, 2007 | 20.45B |
December 31, 2006 | 17.43B |
December 31, 2005 | 17.21B |
December 31, 2004 | 16.17B |
Date | Value |
---|---|
December 31, 2003 | 14.13B |
December 31, 2002 | 12.22B |
December 31, 2001 | 11.26B |
December 31, 2000 | 10.50B |
December 31, 1999 | 10.76B |
December 31, 1998 | 9.027B |
December 31, 1997 | 8.715B |
December 31, 1996 | 10.30B |
December 31, 1995 | 9.096B |
December 31, 1994 | 6.35B |
December 31, 1993 | 6.953B |
December 31, 1992 | 6.798B |
December 31, 1991 | 6.079B |
December 31, 1990 | 5.303B |
December 31, 1989 | 4.616B |
December 31, 1988 | 4.304B |
December 31, 1987 | 3.845B |
December 31, 1986 | 3.389B |
December 31, 1985 | 2.987B |
December 31, 1984 | 2.910B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
20.12B
Minimum
2021
22.18B
Maximum
2019
21.23B
Average
21.51B
Median
2023
SG&A Expense (Annual) Benchmarks
Amgen Inc | 6.179B |
Gilead Sciences Inc | 6.09B |
Eli Lilly and Co | 6.941B |
Merck & Co Inc | 10.50B |
Shockwave Medical Inc | 330.10M |